Quantcast

Latest Abbott Stories

2014-09-16 08:32:10

Moms Value Paid Parental Leave and Flexible Work Arrangements as Abbott Is Recognized for the Fourteenth Consecutive Year ABBOTT PARK, Ill., Sept. 16, 2014 /PRNewswire/ -- Abbott's (NYSE: ABT) long-held commitment to supporting working mothers and their families was acknowledged today by Working Mother magazine. The healthcare company was named among the Top 10 companies in Working Mother's 100 Best Companies list, which commends companies for establishing a corporate culture that...

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-09-14 12:20:52

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time WASHINGTON, Sept. 14, 2014 /PRNewswire/ -- Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic XIENCE family of DES. The trial,...

2014-09-11 16:27:23

ABBOTT PARK, Ill., Sept. 11, 2014 /PRNewswire/ -- Abbott's (NYSE: ABT) board of directors has approved a new share repurchase program and declared a quarterly common dividend. Abbott's board has authorized the repurchase of up to $3 billion of the corporation's common shares. This new authorization is in addition to the $511 million unused portion of the previous program that was announced in June 2013. The purchases may be made from time to time as market conditions warrant and...

2014-09-11 12:22:26

- Abbott Achieved Top Industry Scores for Economic and Social Performance ABBOTT PARK, Ill., Sept. 11, 2014 /PRNewswire/ -- For the second consecutive year, Abbott (NYSE: ABT) was named the leading company in its industry by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate responsibility and sustainability. As the Industry Group Leader in Health Care Equipment & Services, Abbott was one of only 24 companies selected for...

2014-09-08 08:32:09

-Innovative Abbott testing technology may help to identify severe infections sooner WASHINGTON, Sept. 8, 2014 /PRNewswire/ -- A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately $2.2 million (EUR1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly IlL...

2014-08-12 12:27:43

- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug. 12, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) recently issued a National Coverage Determination (NCD) that extends coverage for Medicare beneficiaries in the United States to Transcatheter Mitral Valve Repair with Abbott's (NYSE: ABT) MitraClip(® )System. The MitraClip System is a...

2014-07-28 12:28:41

ABBOTT PARK, Ill., July 28, 2014 /PRNewswire/ -- Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago. "Abbott is designing the...

2014-07-24 08:33:26

New Study Shows Most Breastfeeding Moms Do Not Consistently Consume Enough Ideal Levels of These Key Nutrients ABBOTT PARK, Ill., July 24, 2014 /PRNewswire/ -- Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may not be enough to meet the high nutritional needs during this important time for mom and baby.[1] Abbott (NYSE: ABT), the makers of Similac(®) and experts in infant nutrition for...

2014-07-14 08:25:52

Abbott will retain its branded generics pharmaceuticals business in emerging markets ABBOTT PARK, Ill., July 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business, and will be a publicly traded company. This represents a value of approximately...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related